Skip to content

Discontinued — last reported Q4 '24

CapEx at other companies

AMP
Amphastar PharmaceuticalsAMPH
$9.51M-11.1%
PTH
Pelthos Therapeutics Inc.PTHS
$194K
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$35K-64.6%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$228K+6.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1M0.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$21.76M+73.0%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Talphera, Inc.’s 10-K, filed March 31, 2025, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s capex?
Talphera, Inc. (TLPH) reported capex of $0 in Q4 2024.
What is the long-term trend for Talphera, Inc.'s capex?
Over 2 years (2021 to 2024), Talphera, Inc.'s capex has grown at a -100.0% compound annual growth rate (CAGR), from $1.83M to $0.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.